Table 1. Clinical characteristics of 241 patients.
| Characteristics | Data |
|---|---|
| Patients | |
| Sex | |
| Male | 155/241 (64.3) |
| Female | 86/241 (35.7) |
| Age (years) ± SD | 62.9 ± 9.5 |
| Number of liver metastases before chemotherapy | 3.0 ± 3.0 |
| Tumors | |
| Metastases size (mm) | |
| Mean ± SD | 32.7 ± 22.9 |
| Range | 5.3–204.6 |
| Clinical risk score | |
| Fong’s score | |
| 0 | 7/241 (2.9) |
| 1 | 42/241 (17.4) |
| 2 | 93/241 (38.6) |
| 3 | 84/241 (34.9) |
| 4 | 14/241 (5.8) |
| 5 | 1/241 (0.4) |
| Chemotherapy | |
| Received chemotherapy before surgery | 241/241 (100) |
| First chemotherapy duration (days) | 66.0 ± 50.0 |
| Folfox-based | 217/241 (90.0) |
| 5-fluorouracil-based combination | 239/241 (99.2) |
| Received chemotherapy after surgery | 202/241 (85.9) |
| First post-surgery chemotherapy duration (days) | 91.8 ± 55.6 |
| Folfox-based | 155/202 (76.7) |
| 5-fluorouracil-based combination | 187/202 (92.6) |
Numbers in parentheses are percentages. SD = standard deviation.